NLI
ALXN

Nippon Life Insurance’s Alexion Pharmaceuticals ALXN Stock Holding History

Nippon Life Insurance’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,306
Closed -$1.17M – 307
2017
Q3 		$1.17M Buy
8,306
+20
+0.2% +$2.72K 0.02% 268
2017
Q2 		$1.01M Sell
8,286
-365
-4% -$42.5K 0.02% 288
2017
Q1 		$1.05M Sell
8,651
-2,962
-26% -$382K 0.02% 286
2016
Q4 		$1.42M Buy
11,613
+773
+7% +$94.6K 0.03% 243
2016
Q3 		$1.33M Sell
10,840
-160
-1% -$20.6K 0.03% 240
2016
Q2 		$1.28M Sell
11,000
-595
-5% -$84.4K 0.03% 226
2016
Q1 		$1.61M Buy
11,595
+138
+1% +$20.3K 0.04% 189
2015
Q4 		$2.19M Sell
11,457
-566
-5% -$98.9K 0.06% 130
2015
Q3 		$1.88M Sell
12,023
-252
-2% -$46K 0.05% 171
2015
Q2 		$2.22M Buy
12,275
+1,461
+14% +$252K 0.05% 167
2015
Q1 		$1.87M Buy
10,814
+124
+1% +$22.4K 0.05% 208
2014
Q4 		$1.98M Sell
10,690
-165
-2% -$30.6K 0.05% 199
2014
Q3 		$1.8M Sell
10,855
-873
-7% -$143K 0.05% 216
2014
Q2 		$1.83M Buy
11,728
+1,024
+10% +$162K 0.05% 221
2014
Q1 		$1.63M Sell
10,704
-2,871
-21% -$457K 0.05% 226
2013
Q4 		$1.81M Sell
13,575
-411
-3% -$49.3K 0.05% 222
2013
Q3 		$1.63M Sell
13,986
-3,904
-22% -$428K 0.05% 224
2013
Q2 		$1.65M Buy
+17,890
New +$1.72M 0.05% 224

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nippon Life Insurance's ALXN Position: Q4 2017 in Review

Nippon Life Insurance sold out of Alexion Pharmaceuticals (ALXN) in Q4 2017, closing a stake of 8,306 shares — an estimated $1.17M sold.

Nippon Life Insurance first reported a position in ALXN in Q2 2013 and held it in 18 quarters. The position peaked at $2.22M in Q2 2015. 587 funds tracked by Wall St. Rank hold ALXN as of Q4 2017.

  • Nippon Life Insurance reported no remaining Alexion Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nippon Life Insurance sold 8,306 Alexion Pharmaceuticals shares in Q4 2017, an estimated $1.17M.
  • Nippon Life Insurance first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nippon Life Insurance's Alexion Pharmaceuticals position peaked at $2.22M in Q2 2015.
  • 587 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2017.

Based on Nippon Life Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.